Multiomics profiling of paired primary and recurrent glioblastoma patient tissues

BACKGROUND: Despite maximal therapy with surgery, chemotherapy, and radiotherapy, glioblastoma (GBM) patients have a median survival of only 15 months. Almost all patients inevitably experience symptomatic tumor recurrence. A hallmark of this tumor type is the large heterogeneity between patients an...

Descripción completa

Detalles Bibliográficos
Autores principales: Dekker, Lennard J M, Kannegieter, Nynke M, Haerkens, Femke, Toth, Emma, Kros, Johan M, Steenhoff Hov, Dag Are, Fillebeen, Julien, Verschuren, Lars, Leenstra, Sieger, Ressa, Anna, Luider, Theo M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Basic and Translational Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415260/
https://www.ncbi.nlm.nih.gov/pubmed/32793885
http://dx.doi.org/10.1093/noajnl/vdaa083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415260/
https://www.ncbi.nlm.nih.gov/pubmed/32793885
http://dx.doi.org/10.1093/noajnl/vdaa083

Ejemplares similares